双展齐绽・深耕全球 | 热景生物亮相土耳其 & 摩洛哥医疗展 共拓欧亚非精准诊断新局

2026 年 4 月，热景生物同步亮相土耳其EXPOMED EURASIA 2026与摩洛哥MOROCCO MEDICAL EXPO两大国际医疗展会，以全场景免疫诊断解决方案深耕欧亚、北非核心市场，与全球合作伙伴共话精准诊断新未来。

土耳其・EXPOMED EURASIA 2026

展位信息

时间：2026 年4 月 16–18 日

地点：TUYAP Fair and Congress Center, Istanbul, Turkey

展位号：Hall 7 | Booth 728A

作为连接欧洲与亚洲的重要医疗展会，本次展会汇聚欧洲、中东及中亚地区专业客商。热景生物围绕精准、高效、便捷核心理念，系统展示全场景诊断产品体系：

化学发光平台：MQ60、C800、C2100 系列产品全面覆盖从单人份到中大型实验室的检测需求，实现高灵敏、高通量检测

POCT快速检测平台：UPT2800 上转发光免疫分析系统，兼具高灵敏度与快速响应优势，适用于急诊及基层医疗场景

特色检测项目：TB-IGRA 结核感染检测方案，助力结核病早筛与精准诊断

多样化试剂体系：胶体金（CG）与ELISA产品线，广泛应用于传染病筛查及健康管理领域

依托土耳其战略枢纽地位，热景生物与多国行业伙伴深入交流，在产品引入、渠道建设及本地化服务等方面达成多项合作共识，持续完善欧亚区域营销网络。

摩洛哥・MOROCCO MEDICAL EXPO

展位信息

时间：2026年4月16-19日

地点：ICEC Casablanca, Ain Sebaa, Morocco

展位号：D7

在本届摩洛哥展上，热景生物携多款核心产品亮相，展示从POCT到实验室全自动化学发光免疫分析的完整解决方案，为全球医疗机构提供精准、高效的诊断体验：

MQ60 单人份化学发光免疫分析仪–灵活高效，专为小中型实验室设计

UPT2800 上转发光免疫分析仪–高灵敏度POCT检测方案，快速精准

结核感染γ干扰素释放试验 (TB-IGRA)–快速诊断结核感染的利器

胶体金快速检测卡 (CG) & 酶联免疫试剂盒 (ELISA)–覆盖多种传染病及健康管理需求

展会期间，热景生物秉持全球化 + 本地化战略，与全球合作伙伴达成渠道拓展、创新产品合作等多项战略意向，稳步深耕北非市场。

双展联动 全球布局

本次欧亚非双展齐发，热景生物以多技术路径融合的全场景诊断方案，强化全球体外诊断市场竞争力。未来，公司将持续完善全球营销网络与服务体系，推动优质诊断资源广泛落地，与全球伙伴共筑精准诊断健康生态。

Two Exhibitions, One Global Vision | Hotgen Biotech Shines at Turkey & Morocco Medical Expos, Exploring Precision Diagnostics Across Eurasia and Africa

In April 2026, Hotgen Biotech participated in two major international medical exhibitions simultaneously – EXPOMED EURASIA 2026 (Turkey) and MOROCCO MEDICAL EXPO (Morocco). With comprehensive scenario-based immunodiagnostic solutions, we deepened our presence in key Eurasian and North African markets and discussed the future of precision diagnostics with global partners.

Turkey · EXPOMED EURASIA 2026

Exhibition Information

Date: April 16–18, 2026

Venue: TUYAP Fair and Congress Center, Istanbul, Turkey

Booth: Hall 7 | Booth 728A

As a vital medical exhibition connecting Europe and Asia, this event attracted professional buyers from Europe, the Middle East and Central Asia. Centered on the core principles of precision, efficiency and convenience, Hotgen Biotech systematically displayed its full-scenario diagnostic product portfolio:

CLIA Platform:The MQ60, C800, and C2100 series comprehensively address testing needs ranging from mono-test applications to medium and large laboratories, delivering high sensitivity and high-throughput performance.

POCT Rapid Testing Platform:The UPT2800 Up-Converting Phosphor Technology combines high sensitivity with rapid response, making it ideal for emergency and primary healthcare settings.

Specialized Testing Solutions:The TB-IGRA solution supports early screening and accurate diagnosis of tuberculosis infection.

Diverse Reagent Portfolio:Colloidal Gold (CG) and ELISA product lines are widely applied in infectious disease screening and health management.

Leveraging Turkey’s strategic hub position, Hotgen Biotech conducted in-depth exchanges with industry partners from various countries, reached multiple cooperation agreements on product introduction, channel development and localized services, and continuously improved the Eurasian regional marketing network.

Morocco · MOROCCO MEDICAL EXPO

Exhibition Information

Date: April 16–19, 2026

Venue: ICEC Casablanca, Ain Sebaa, Morocco

Booth No.: D7

At this year’s Morocco Medical Expo, Hotgen presents a range of flagship products, showcasing a complete diagnostic solution spanning from POCT to fully automated chemiluminescence immunoassay systems. These solutions are designed to deliver accurate and efficient diagnostic experiences for healthcare providers worldwide:

MQ60 Mono-test Chemiluminescence Immunoassay Analyzer – Flexible and efficient, designed for small to medium-sized laboratories

UPT2800 Up-converting Phosphor Technology Immunoassay Analyzer – High-sensitivity POCT solution with rapid and precise results

TB-IGRA (Tuberculosis Interferon-Gamma Release Assay) – A powerful tool for rapid detection of tuberculosis infection

Colloidal Gold Rapid Test (CG) & ELISA Kits – Covering a wide range of infectious diseases and health management needs

During the exhibition, guided by the Globalization + Localization strategy, Hotgen Biotech reached multiple strategic intentions on channel expansion and innovative product cooperation with global partners, steadily deepening its presence in the North African market.

Dual Exhibition Synergy, Global Layout

With the simultaneous launch of two exhibitions across Eurasia and Africa, Hotgen Biotech has strengthened its competitiveness in the global in vitro diagnostics market through full-scenario diagnostic solutions integrated with multiple technological approaches. In the future, the company will continuously improve its global marketing network and service system, promote the wide implementation of high-quality diagnostic resources, and build a healthy ecosystem of precision diagnostics together with global partners.